Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BT-588 by Biotest for Community Acquired Pneumonia: Likelihood of Approval
BT-588 is under clinical development by Biotest and currently in Phase III for Community Acquired Pneumonia. According to GlobalData, Phase...
BT-588 by Biotest for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
BT-588 is under clinical development by Biotest and currently in Phase III for Coronavirus Disease 2019 (COVID-19). According to GlobalData,...
Yimmugo by Biotest for Primary Immune Deficiency (PID): Likelihood of Approval
Yimmugo is under clinical development by Biotest and currently in Phase III for Primary Immune Deficiency (PID). According to GlobalData,...